Thus, we speculated that DGKZ might regulate MYC signal pathway via possible interaction with ERK1/2 in carcinogenesis of osteosarcoma and utilization of DGKZ-ERK1/2-MYC interacting axis inhibitor might be an effective approach in treatment of osteosarcoma. This evidence concerns the gene DGKZ and osteosarcoma.